Logo
Logo

About Rivastigmine Hydrogen Tartrate API

Product
  • Therapeutic CategoryCentral Nervous System (CNS)

  • CAS Number

    129101-54-8

  • API Technology

    Synthetic

  • Dose Form

    Film (Transdermal), Oral Solid/Capsules

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, CEP Submitted, EUDMF, China DMF

Mechanism of Action

Rivastigmine is a type of medicine called an acetylcholinesterase inhibitor. It works by slowing the breakdown of a neurotransmitter in the brain called acetylcholine.

Indication

EXELON is an acetylcholinesterase inhibitor indicated for treatment of:

  • Mild to moderate dementia of the Alzheimer’s type
  • Mild to moderate dementia associated with Parkinson’s disease

Related APIs

Eslicarbazepine Acetate-es

Central Nervous System (CNS)

arrow

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.